You say... what do we do?
We relax and sit back and let this super team of our management who locked in 3 local to their own country Pharmaceutical local giants that are distributors in heavily populated countries into contracts to help acquire EUA‘s or compassionate use or equivalents for Leronlimab.
This is quite the accomplishment for our management team and they have even set up global distribution as the future results of Leronlimab become known around the world. At this point I fully expect our international sales to happen long before our in country sales on any indication that could happen. We have chosen a pathway of going international and frankly our management has hit the ground running and it looks like success is on the way. I am pretty proud of our management for locking up 3 separate deals in short order. We should be talking bonuses for them but instead all you hear is complaining and whining about the management. If these people would just open their eyes and look to the immediate future you will see what is on the horizon. It’s being laid out there for all to see. Open your eyes...
Let’s hope that our new found top line CD-12 results help us to acquire a quick EUA equivalent in one of these countries or if it takes a fast interim look at the CD-16 or 17 trial that could have undeniable results that will be accepted all over the planet.
With new trials designed to hit their primary endpoints line we designed these new trials too with estimated ease. I even heard Dr. Recknor let some confidence slip and say that primary end points are now designed to be hit easily. I am sure that was an over confident slip by the new doctor. But you can see his view clearly expressed in the web call.
We have learned some hard lessons and instead of trying for a difficult primary endpoint of mortality we will choose the easy attainable path and have our mortality endpoint as a secondary end point and have a much easier achievable primary endpoint. These were some expensive lessons but as with everything in life we learned from our trial designs. I don’t know how anyone can be unsatisfied with the management right now. We are hitting on all cylinders. Things look super positive. Even quick interim results could only be 2-4 months away depending on how fast the trial fills.
Revenue is closer than ever and yet some complain. Well it’s a last ditch effort by the whiners to try to replace some or all of the management. The way I see it... in the next few months the management will be loved by all. All it takes is revenue money to make everyone happy. They will be hero’s and write their own ticket to stay as long as they ever wanted to at CytoDyn. The whiners will have nothing they can say... those days I am looking forward too. To shut up the many doubters.
Let’s hope things work as planned...
We relax and sit back and let this super team of our management who locked in 3 local to their own country Pharmaceutical local giants that are distributors in heavily populated countries into contracts to help acquire EUA‘s or compassionate use or equivalents for Leronlimab.
This is quite the accomplishment for our management team and they have even set up global distribution as the future results of Leronlimab become known around the world. At this point I fully expect our international sales to happen long before our in country sales on any indication that could happen. We have chosen a pathway of going international and frankly our management has hit the ground running and it looks like success is on the way. I am pretty proud of our management for locking up 3 separate deals in short order. We should be talking bonuses for them but instead all you hear is complaining and whining about the management. If these people would just open their eyes and look to the immediate future you will see what is on the horizon. It’s being laid out there for all to see. Open your eyes...
Let’s hope that our new found top line CD-12 results help us to acquire a quick EUA equivalent in one of these countries or if it takes a fast interim look at the CD-16 or 17 trial that could have undeniable results that will be accepted all over the planet.
With new trials designed to hit their primary endpoints line we designed these new trials too with estimated ease. I even heard Dr. Recknor let some confidence slip and say that primary end points are now designed to be hit easily. I am sure that was an over confident slip by the new doctor. But you can see his view clearly expressed in the web call.
We have learned some hard lessons and instead of trying for a difficult primary endpoint of mortality we will choose the easy attainable path and have our mortality endpoint as a secondary end point and have a much easier achievable primary endpoint. These were some expensive lessons but as with everything in life we learned from our trial designs. I don’t know how anyone can be unsatisfied with the management right now. We are hitting on all cylinders. Things look super positive. Even quick interim results could only be 2-4 months away depending on how fast the trial fills.
Revenue is closer than ever and yet some complain. Well it’s a last ditch effort by the whiners to try to replace some or all of the management. The way I see it... in the next few months the management will be loved by all. All it takes is revenue money to make everyone happy. They will be hero’s and write their own ticket to stay as long as they ever wanted to at CytoDyn. The whiners will have nothing they can say... those days I am looking forward too. To shut up the many doubters.
Let’s hope things work as planned...
10
